SAREPTA THERAPEUTICS INC's ticker is SRPT and the CUSIP is 803607100. A total of 342 filers reported holding SAREPTA THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is 0.71 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $888,592 | -60.2% | 7,493 | -61.9% | 0.00% | -75.0% |
| Q2 2023 | $2,230,469 | +77.4% | 19,649 | +115.4% | 0.00% | +33.3% |
| Q1 2023 | $1,256,966 | -96.8% | 9,123 | -97.0% | 0.00% | -97.0% |
| Q4 2022 | $38,936,162 | +228936.2% | 300,480 | +190077.2% | 0.10% | – |
| Q3 2022 | $17,000 | +41.7% | 158 | 0.0% | 0.00% | – |
| Q2 2022 | $12,000 | 0.0% | 158 | 0.0% | 0.00% | – |
| Q1 2022 | $12,000 | -14.3% | 158 | 0.0% | 0.00% | – |
| Q4 2021 | $14,000 | – | 158 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Perceptive Advisors | 2,878,979 | $69,182,000 | 7.27% |
| Eventide Asset Management | 259,100 | $6,226,000 | 0.97% |
| GLADE BROOK CAPITAL PARTNERS LLC | 251,000 | $6,032,000 | 0.93% |
| IMS Capital Management | 32,215 | $774,000 | 0.91% |
| Perceptive Advisors | 350,000 | $8,413,000 | 0.88% |
| Benchmark Capital Advisors | 34,900 | $839,000 | 0.58% |
| BECK CAPITAL MANAGEMENT, LLC | 24,744 | $636,000 | 0.49% |
| SABBY MANAGEMENT, LLC | 352,100 | $8,461,000 | 0.47% |
| Hatteras Alternative Mutual Funds, LLC | 39,404 | $947,000 | 0.46% |
| Potomac Capital Management, Inc. | 22,100 | $531,000 | 0.45% |